Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel poliglumex vs paclitaxel in advanced/metastatic breast cancer
CTR20132193Phase 2Active
- Sponsor
- Sichuan Yuansheng Biological Pharmaceutical
- Start
- Mar 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in breast cancer, sponsored by Sichuan Yuansheng Biological Pharmaceutical. Started Mar 2014; status: active.
02
Drugs
paclitaxel poliglumex
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20132193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132193.